AbbVie picks Unilife for syringes; Indian regulator criticizes the 'lackadaisical attitude' of companies;

> Unilife has won a $5 million contract from AbbVie ($ABBV) for development and supply of prefilled syringes and reusable auto-injectors for certain drugs in its "portfolio for the treatment of autoimmune diseases." Filing

> A state regulator in India has warned the industry that some of its problems with the FDA stem from a "lackadaisical attitude of the pharma industry personnel which also include senior management officials." Report

> U.S.-based pharma manufacturing and lab equipment maker SP Industries has acquired privately held Stability Environments for an undisclosed sum. Report

Suggested Articles

Gilead expects to sell 1 million to 1.5 million treatment courses of remdesivir in 2020. That means about $3.5 billion in sales, one analsyt figures.

Pfizer and BioNTech followed supply pacts in the U.S. and U.K. with a new deal to deliver 120 million vaccines to Japan in the first half of 2021.

Warp Speed's largest outlay to date, the funding will cover development and manufacturing scale-up of a vaccine that uses proven Sanofi technology.